Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1061 studies found for:    "Hepatitis B"
Show Display Options
Rank Status Study
21 Completed Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants
Condition: Hepatitis B
Interventions: Biological: Engerix™-B;   Biological: HBV-MPL vaccine (208129);   Biological: Hepatitis B vaccine, experimental formulation
22 Completed Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B
Condition: Hepatitis B
Interventions: Biological: MPL-Adjuvanted recombinant hepatitis B vaccine;   Biological: Engerix™-B
23 Active, not recruiting Study for Consolidation Period of Chronic Hepatitis B
Condition: Hepatitis B
24 Unknown  Hepatitis B Seroepidemiology Among Young Adults
Condition: Hepatitis B
25 Completed Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians
Condition: Hepatitis B
Intervention: Other: Data collection
26 Completed A Study of the Immune Response to Heplisav in Healthy Older Adults
Condition: Hepatitis B
Intervention: Biological: HEPLISAV
27 Completed Hepatitis B Acceptability and Vaccination Incentive Trial
Condition: Hepatitis B
Intervention: Other: Incentive condition
28 Completed Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator
Condition: Hepatitis B
Intervention: Biological: Resiquimod gel
29 Unknown  A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults
Condition: Hepatitis B
Intervention: Biological: Hepatitis B vaccine
30 Completed Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine
Condition: Hepatitis B
Interventions: Biological: HBsAg formulated with different concentrations of MPL and Aluminium Salts;   Biological: Engerix™-B
31 Withdrawn Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation
Condition: Hepatitis B, Chronic
Intervention: Biological: Nabi-HB
32 Completed
Has Results
Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.
Condition: Hepatitis B Vaccine
Intervention: Biological: Engerix™-B Kinder
33 Completed Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders
Condition: Hepatitis B
Interventions: Biological: Recombinant MPL- adjuvanted hepatitis B vaccine;   Biological: Engerix™-B
34 Completed Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B
Condition: Hepatitis B
Interventions: Biological: Engerix™-B;   Biological: HBV-MPL 208129;   Biological: Vaccine containing HBsAg absorbed on aluminium salts - experimental formulation
35 Unknown  Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
Condition: Hepatitis B
36 Completed
Has Results
Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)
Condition: Hepatitis B Virus Infection
Interventions: Biological: Comparator: modified process hepatitis B vaccine;   Biological: Comparator: ENGERIX-B™
37 Active, not recruiting Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: NVR 3-778;   Drug: Placebo for NVR 3-778;   Drug: Pegasys
38 Terminated Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)
Condition: Hepatitis B
Interventions: Drug: Lamivudine;   Biological: Recombinant hepatitis B surface antigen
39 Active, not recruiting Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
Condition: Hepatitis B
Intervention: Drug: Entecavir and peginterferon
40 Completed Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders
Condition: Hepatitis B
Interventions: Biological: HBVaxPro;   Biological: HBAI20

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.